These constraints of the BTNX NTS are extremely appropriate, as we discovered e.g. etodesnitazene to obtain the same in vitro potency and efficacy as fentanyl [7, thirteen] and as it may well potentially give PWUD a Wrong sense of security. Also, the detectability of nitazene analogues in drug samples can be impacted by solubility challenges, as hi